Botanical species · safety record

Sequoiadendron giganteum

The EFSA Compendium of Botanicals holds 18 constituent measurements for Sequoiadendron giganteum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Sequoiadendron giganteum (Lindl.) J.Buchholz

18Constituent measurements

0Safety records

4Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Sequoiadendron giganteum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Fresh

Source material stated

Young shoots

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Elemicin	Leaves	Essential oil	≤ 6.2 Percent	Chromatographic tests	Resolve DOI
Elemicin	Leaves	Essential oil	≥ 0.8 Percent	Chromatographic tests	Resolve DOI
Eugenol	Leaves	Essential oil	≤ 2.1 Percent	Chromatographic tests	Resolve DOI
Eugenol	Leaves	Essential oil	≥ 0.7 Percent	Chromatographic tests	Resolve DOI
Myrcene	Leaves	Essential oil	≥ 7.6 Percent	Chromatographic tests	Resolve DOI
Myrcene	Leaves	Essential oil	≤ 9.4 Percent	Chromatographic tests	Resolve DOI
Safrole	Leaves	Essential oil	≥ 0.2 Percent	Chromatographic tests	Resolve DOI
Safrole	Leaves	Essential oil	≤ 5.7 Percent	Chromatographic tests	Resolve DOI
Elemicin	Leaves	Essential oil	21.8 Percent	GC-MS	No resolvable identifier
Lignans	Wood	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Methyleugenol	Leaves	Essential oil	4.3 Percent	GC-MS	No resolvable identifier
Methylisoeugenol	Leaves	Essential oil	1.2 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	6.4 Percent	GC-MS	No resolvable identifier
Myrcene	Wood	Essential oil	7.9 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	≤ 12.1 Percent	GC-MS	No resolvable identifier
Myrcene	Leaves	Essential oil	≥ 6.4 Percent	GC-MS	No resolvable identifier
Safrole	Leaves	Essential oil	≥ 0.1 Percent	GC-MS	No resolvable identifier
Safrole	Leaves	Essential oil	≤ 1 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Jerkovic, I., Mastelic, J., Milos, M. Chemical composition of the essential oil of Sequoiadendron giganteum (Lindl.) Buchh. cultivated in Croatia. JOURNAL OF ESSENTIAL OIL RESEARCH, 2003, vol. 15, no. 1, p. 36-38.
Henley-Smith, P., Whiting, D. A. New norlignans of Sequoiadendron gigantea; phytochemical comparison with Sequoia sempervirens. Phytochemistry (Elsevier), 1976, p. 1285-1287.
LEVINSON, AS., LEMOINE, G., SMART, EC. VOLATILE OIL FROM FOLIAGE OF SEQUOIADENDRON-GIGANTEUM - CHANGE IN COMPOSITION DURING GROWTH. PHYTOCHEMISTRY, 1971, vol. 10, no. 5, p. 1087-&. DOI
Chalchat, J. C., Garry, R. P., Michet, A. Constituents of Sequoiadendron giganteum Buchh. leaf oils (Giant sequoia). Flavour and Fragrance Journal, 1988, p. 69-72.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature